VRG Therapeutics

VRG Therapeutics is an innovative biotechnology company headquartered in Budapest, focused on the discovery and development of next-generation miniprotein therapeutics targeting challenging biological mechanisms. The company leverages its proprietary AI-MPRO platform, which integrates computational protein design, high-throughput screening, and machine learning–driven analytics to generate highly selective and potent drug candidates. With a strong scientific foundation and an experienced team, VRG Therapeutics is advancing a growing pipeline of therapeutic programs with the potential to deliver differentiated best-in-class and first-in-class treatments.

Content by VRG Therapeutics

Genetic material in a pill, surrounded by computational imagery.
| 2 min read
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A 3D rendering illustrates a sandwich ELISA technique, where antigen detection is achieved between two layers of antibodies: a capture antibody and a detection antibody
Learn the key characteristics that determine whether an immunoassay generates accurate and reproducible data.
Illustration of translucent Y-shaped antibodies floating in a soft blue and green background, representing antibody research, development, and biomedical science.
Explore how antibody accessibility and custom development strategies can influence the pace and success of translational research.
Digital illustration of a glowing DNA double helix surrounded by interconnected circuit-like lines on a dark blue background.
Learn the key differences between chemical and enzymatic approaches to synthetic DNA production and their implications for modern research.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue